Loading
eGFR 60-89 with kidney damage — still mostly silent, but the protection plan tightens.
Evidence reviewed & updated: 2026-07 — based on KDIGO 2024, KDOQI, and published trial data.
Stage 2 kidney disease means eGFR 60-89 mL/min/1.73m² with evidence of kidney damage (albuminuria, hematuria, or structural changes). Like stage 1, most patients have no symptoms. The treatment principles mirror stage 1 but monitoring tightens — and this is the ideal window to start SGLT2 inhibitor therapy for albuminuric patients.
eGFR 60-89 is technically 'mildly decreased' — but by itself, in an older adult, it can be normal aging. The CKD diagnosis requires the damage marker. The combination (mildly reduced function + damage marker) defines stage 2 and predicts a much higher progression risk than either finding alone.
An eGFR of 60-89 with UACR >300 mg/g (A3) carries significantly higher progression risk than eGFR 45-59 with no albuminuria (A1) — the KDIGO heat map captures this. Staging is about risk, not just the number.
Progression rate varies by cause: diabetic kidney disease progresses ~2-4 mL/min/year on average without treatment; with optimal therapy (SGLT2i + BP control), progression can slow to near-zero for many patients.
All stage 1 interventions apply, plus: (1) formalize kidney-protective therapy — start SGLT2 inhibitor if albuminuric (UACR >200 mg/g) with eGFR >20 (KDIGO 2024 strong recommendation), (2) optimize ACEi/ARB to maximum tolerated dose (proteinuria reduction is dose-dependent), (3) target BP <130/80, (4) begin CKD education — most patients don't know about kidney disease at this stage, and education changes adherence.
Monitor: UACR and eGFR every 6-12 months (more often if progressing); potassium yearly (more often with ACEi/SGLT2i initiation); HbA1c quarterly if diabetic.
Vaccination: hepatitis B series (before dialysis is needed — response is better early), annual influenza, and pneumococcal vaccines. This is the stage where the HBV vaccine is most effective.
The big modifiable accelerators: uncontrolled hypertension (the #1 driver), NSAID use (very common in India — diclofenac, ibuprofen, mefenamic acid), repeated dehydration (common in summer, manual labor), uncontrolled diabetes, smoking, and high-protein fad diets.
Non-modifiable: genetic predisposition, cause of CKD, age at diagnosis, baseline albuminuria level. Knowing your progression rate (eGFR slope) after 2 years of treatment is the best predictor — a stable slope means the plan is working.
Pregnancy: women with stage 2 CKD should plan pregnancies with nephrology input — pre-pregnancy counseling and BP control reduce maternal and fetal risks.
Advertisement
Function is now measurably reduced — symptoms begin, monitoring tightens, and treatment intensifies.
Learn moreKidney disease is silent — but these 10 warning signs deserve a urine and blood test today.
Learn moreHypertension is the #2 cause of kidney failure in India — and damaged kidneys raise blood pressure. Break the cycle.
Learn moreZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.